Several lines of evidence suggest the existence of multiple dopamine receptor subtypes, referred to as D, and D,. The present study examines the distribution of these dopamine binding sites in the rat brain and pituitary in relation to the distribution of D, receptor mRNA using a combination of in vitro receptor autoradiographic and in situ hybridization techniques.
3H-Raclopride and 3H-SCH23390 (in the presence of 1 ELM ketanserin)
were used to label D, and D, receptor binding sites, respectively, while a 495 bp cRNA probe synthesized from the Sac I-Bglllfragment of a rat D, receptor cDNA was used to visualize the D, receptor mRNA. Analysis of adjacent tissue sections in which receptor autoradiography and in situ hybridization had been performed revealed several brain regions where the D, binding site and corresponding mRNA appear to be similarly distributed, including the caudate-putamen, nucleus accumbens, olfactory tubercle, globus pallidus, substantia nigra, and ventral tegmental area. In the pituitary gland, D, binding sites and mRNA appear to be codistributed with very dense levels in the intermediate lobe and individually labeled cells in the anterior lobe. Brain regions demonstrating a lack of correspondence between the distribution of the D, binding site and D, receptor mRNA include the olfactory bulb, neocortex, paleocortex, hippocampus, and zona incerta. Several hypotheses are discussed to explain the lack of correspondence in certain brain regions; these include the localization of receptor binding sites on both fibers and cell bodies and receptor transport. These studies provide a better understanding of the anatomical distribution of the D, receptor and serve as a framework for future regulatory and anatomical mapping studies. By focusing on specific brain regions, such as the nigrostriatal system, hippocampus, and olfactory bulb, they provide insights into D, receptor synthesis, transport, and insertion into cell membranes.
Cumulative evidence suggests the existence of at least 2 distinct dopaminergic receptor subtypes, referred to as D, and D,. D, dopamine (DA) receptors are positively coupled to adenylate cyclase (Stoof and Kebabian, 1984) , widely distributed in the CNS (Boyson et al., 1986; Dawson et al., 1986; Dubois et al., 1986; Bouthenet et al., 1987; Wamsley et al., 1989) , and abundant in the parathyroid gland (Attie et al., 1980) . D, DA receptors, on the other hand, are either not coupled to adenylate cyclase (Memo et al., 1986) or negatively coupled (Onali et al., 1985) and are densely distributed in the basal ganglia (Martres et al., 1985; Charuchinda et al., 1987; Joyce and Marshall, 1987; Richfield et al., 1987) and pituitary gland (Kohler and Fahlberg, 1985; Pazos et al., 1985; DeSouza, 1986) .
Selective lesion studies (Creese et al., 1977; Nagy et al., 1978; Schwartz et al., 1978; Cross and Waddington, 1981; Joyce and Marshall, 1987; Trugman and Wooten, 1987; Filloux et al., 1988; Porceddu et al., 1986) suggest that while D, and D, receptors are both localized on pre-and postsynaptic membranes, the D, subtype may function as an "autoreceptor," modulating the synthesis and/or release of DA. Support for this hypothesis has come from findings demonstrating that D, receptors can be localized on DA-containing cells (Reisine et al., 1979) and that application of selective D, agonists produces a decrease in cell firing (White and Wang, 1983 ) DA release, and synthesis (Stoof et al., 1982; Brown et al., 1985) . Similar changes in DA release and turnover have not been observed with selective D, receptor agonists (Stoof et al., 1982; Brown et al., 1985; Clark and Galloway, 1985) .
The rat D, receptor has been recently cloned (Bunzow et al., 1988) and is structurally similar to members of the family of G protein-coupled receptors that include the o(-and @-adrenergic receptors, the muscarinic receptors and rhodopsin. Northern blot analysis suggests that the mRNA coding for the D, receptor shows a similar distribution to the D, sites reported with ligand binding, with high levels observed in the striatum and pituitary. Further, transfection of the D, receptor DNA into cells normally not demonstrating DA receptors results in the expression of specific D, receptor binding.
Given these findings, we have recently examined the distribution of the D, receptor mRNA using in situ hybridization (Meador-Woodruff et al., 1989) . D, receptor mRNA was visualized in DA projections fields, such as the caudate-putamen, nucleus accumbens, and olfactory tubercle, as well as in dopamine-containing cell groups such as the substantia nigra (SN), ventral tegmental area (VTA), and zona incerta. Such a distri- (Mansour et al., 1990) .
The purpose of the present set of studies is to compare the distribution of D, receptor mRNA in the brain and pituitary to D, and D, binding sites using a combination of in situ hybridization and in vitro receptor autoradiographic techniques. These anatomical studies provide a more precise analysis of the distribution of D, receptor mRNA and dopaminergic ligand binding sites than is possible with Northern analysis and homogenate binding. Moreover, while the transfection studies (Bunzow et al., 1988 ) discussed previously are essential for identifying a D, receptor, studies combining in situ hybridization and receptor autoradiography are necessary in supporting, validating, and extending these findings to the CNS.
Several quantitative studies are available describing the distribution of D, and D, binding sites in the brain (e.g., Bouthenet et al., 1987; Charuchinda et al., 1987; Wamsley et al., 1989) . It is not the focus of the present study to replicate these findings, but to examine in serial sections the distribution of the mRNA encoding for the D, receptor in relation to the DA binding sites to gain insights into regions of possible receptor synthesis, transport, and eventual insertion into neuronal membranes. The ligands chosen for these comparisons were 3H-raclopride and 3H-SCH23390,2 DA antagonists highly selective for the D, and D, (Iorio et al., 1983) sites, respectively.
Given the complexity of such a study, this report focuses on regions of the CNS whose anatomical circuitry is better understood, such as the olfactory bulb, hippocampus, and the basal ganglia, with minimal discussion of other regions of the rat forebrain and midbrain. The pituitary gland is also examined in detail, as this tissue contains a high density of D, receptors, and differences in receptor binding and mRNA distribution are unlikely to be due to the localization of D, binding sites on fibers. In addition to these anatomical considerations, several in situ hybridization and receptor binding controls were performed to ensure selectivity of hybridization and ligand binding.
Materials and Methods
Tissue preparation and incubation medium for receptor binding studies. Adult male Sprague-Dawley rats (Charles River, 200-250 gm) were sacrificed by decapitation, and their brains and pituitaries were quickly removed. Brains were frozen in liquid isopentane (-30°C) for 30 set, while the pituitaries were frozen on crushed dry ice in Lipshaw M-l embedding matrix. Frozen tissues were sectioned on a Bright cryostat (20 pm), thaw-mounted on precleaned and subbed microscope slides, and stored at -80°C. Immediately prior to using the tissue, the slidemounted sections are gradually brought to room temperature and incubated (90 min, 22°C) with 200400 ~1 of either the D,-selective antagonist 'H-raclopride (83.4 Ci/mmol, New England Nuclear) or the D,-selective antagonist 'H-SCH23390 (7 1.3 Ci/mmol, New England Nuclear) in 50 mM Tris buffer, pH 7.5 at 25°C containing 0.1% ascorbic acid, 120 mM NaCl, 5 mM KCl, and 1 mM MgCl,. As SCH23390 has been reported to bind serotinergic sites (5HT,), 1 PM ketanserin, a selective 5-HT, antagonist was added to all )H-SCH23390 binding studies.
Following a 90 min incubation period, the slides were drained, washed in 4 consecutive 250 ml, 50 mM Tris, pH 7.6 at 4°C washes containing 0.1% ascorbic acid, 120 mM NaCl, 5 mM KCl, and 1 mM MgCl,. Slides incubated with 3H-raclopride were given four 2-min washes, while those labeled with jH-SCH23390 were given four 4-min washes. All slides were then quickly dipped in 250 ml distilled water (4°C) and dried with a portable hair dryer set to "cool." Nonspecific binding was evaluated by treating a parallel set of slides with the same concentrations of tritiated ligand with a 1 PM final concentration of an unlabeled competitor: spiperone to displace 3H-raclopride and SCH23390 to displace 3H-SCH23390.
Saturation studies. Prior to preparing tissue for receptor autoradiography, saturation experiments were performed on slide-mounted brain sections to determine the binding kinetics of 3H-raclopride and )H-SCH23390. Forebrain sections were incubated with a minimum of 8 concentrations of either 3H-raclopride (15.0-O. 12 nM) or 'H-SCH23390 (7.6-0.06 nM) and washed and dried as described earlier. The binding was quantified by placing brain sections in scintillation vials containing 10 ml of scintillant and vigorously shaking for 30 min in a metabolic shaker. Each data point is an average of 2 brain sections. Saturation experiments were performed at least twice and graphed as Scatchard plots. Kd and B,,, values were determined with the LIGAND program developed by Munson and Rodbard (1980) . Competition studies. To characterize the binding sites labeled by 3H-raclopride and 'H-SCH23390, competition studies were performed with slide-mounted brain sections at concentrations 3 times the Kd value for each ligand. These concentrations correspond to the ones used in subsequent autoradiographic mapping studies and represent a 75% receptor occupancy for each ligand. Competition studies were performed with a series of dopaminergic compounds [haloperidol, chlorpromazine, spiperone, (+) and (-) butaclamol, droperidol, raclopride, and SCH233901, as well as nondopaminergic drugs (propranolol, clonidine, mianserin, and bremazocine). The brain sections were incubated, washed, and dried, and the binding was quantified as described earlier.
Autoradiographic mapping. After being brought to room temperature, slide-mounted sections were placed in incubation chambers and incubated with either 'H-raclopride (5.7 nM) or jHSCH23390 (4.4 nM). These concentrations correspond approximately to 3 times the Kd value for each ligand, producing an equivalent receptor occupancy. Following a 90 min incubation, the slides were washed and dried, as described above, and apposed to tritium-sensitive Hyperfilm (Amersham) for 24 weeks (3H-SCH23390) or 4-8 weeks (SH-raclopride). The Hyperfilm was exposed at room temperature, developed in Kodak D-19 (4 min, 19°C) agitated in 2% acetic acid (30 set), fixed in Kodak Rapidfix (5 min), and washed under running water (30 min). Anatomical structures were determined using Nissl-stained sections in conjunction with the atlas of Paxinos and Watson (1986) .
In situ hybridization. Slides adjacent to those used for autoradiographic mapping of D, and D, receptor binding sites were directly removed from storage at -80°C and placed into 4% formaldehyde for 60 min (22°C) prior to being processed for in situ hybridization (Sherman et al., 1986; Watson et al., 1987) . Following three 5-min rinses in PBS, pH 7.4, sections were treated with proteinase K (1 Kg/ml in 100 mM Tris, pH 8.0, 50 mM EDTA) for 10 min at 37°C. Slides were then rinsed in water, followed by 0.1 M triethanolamine, pH 8.0, and treated with a mixture of 0.1 M triethanolamine. uH 8.0. and acetic anhvdride (400: 1, vol/vol) with stirring for 10 min: The sections were then rinsed in 2 x SSC (300 mM NaCl, 30 mM sodium citrate, pH 7.2) for 5 min, dehydrated through graded alcohols, and allowed to air dry.
Brain sections were hybridized with 35S-UTP-labeled riboprobes generated to the 495 Sac I-Bgl ZZ fragment of a rat D, receptor (Bunzow et al., 1988) . cRNA probes were diluted in hybridization buffer (75% formamide, 10% dextran sulfate, 3 x SSC, 50 mM Na,PO,, pH 7.4, 1 xDenhardt's, 0.1 mg/ml yeast tRNA, 0.1 m&ml sonicated, denatured salmon sperm DNA, 10 mM dithiothrietol) to result in a final concentration of 2 x 10" dpm/30 ~1. Volumes of 30 and 50 ~1 of diluted probe were applied to coronal and horizontal sections, respectively.
After hybridization (overnight, 55"(Z), the slides were rinsed in 2 x SSC (5 min) and treated with RNase A (200 pg/rnl in 100 mM Tris, pH 8.0, and 0.5 M NaCl) for 30 min at 37°C. Subsequently, sections were rinsed in 2 x SSC for 10 min (22"C), 1 x SSC for 10 min (22"Q 0.5 x SSC at 55°C for 60 min, 0.5 x SSC at room temperature for 10 min, and finally dehydrated in graded alcohols and air-dried. Sections were then either exposed to Kodak XAR-5 X-Ray film for l-3 d and developed, or dipped in Kodak NTB-2 emulsion and stored at 4°C for 6-17 d prior to development.
In situ hybridization controls. To ensure the specificity of the in situ hybridization signal, several control studies were performed. (1) The 495 bp cRNA probe used in the present study corresponds to the pu- tative third cytosolic loop and the sixth and seventh transmembrane domains ofthe D, receptor. Given the homology ofthe sixth and seventh transmembrane domains to other G-protein coupled receptors, such a probe may potentially hybridize these receptors in addition to the D, receptor. To examine this issue, we performed in situ hybridization with a subcloned 205 bp fragment (EcoRI-Xho II) of the 495 bp clone that codes exclusively for the third cytosolic loop. A series of adjacent brain sections were hybridized either with the 205 bp or the 495 bp cRNA probes employing the same in situ conditions described above. (2) For RNase control, a series of paired, adjacent sections was divided into 2 sets: One slide from each pair was treated as described earlier for in situ hybridization, and the remaining slides from each pair were fixed in 4% formaldehyde and rinsed in PBS, but prior to treatment with proteinase K, were incubated with RNase A (200 &ml) for 30 min at 37°C. These slides were then processed as described in the in situ hybridization protocol. (3) For "sense''-strand control, another series of paired, adjacent sections was divided into 2 sets: One set was treated according to the in situ hybridization protocol, and the second set was treated identically, except that the cRNA used in the hybridization mixture was %S-UTP-labeled "sense''-strand RNA.
Results

Saturation studies 3H-raclopride
and 3H-SCH23390 demonstrate saturable binding, and the results best fit a single-site model using the LIGAND program. As can be seen from Figure 1 , 3H-raclopride and 3H-SCH23390 bound to a single population of sites with apparent affinity constants of 1.7 and 1.5 nM, respectively. The mean Kd values across multiple saturation studies are 2.2 nM for 3H-raclopride and 1.55 nM for 3H-SCH23390. While the affinities of these ligands for their respective binding sites appear similar, the relative abundance of each receptor varied markedly. In the forebrain slices used in the present study, there were 4 times as many D, sites (86.0 fmol/mg) as D, sites (20.0 fmol/mg) per milligram of tissue.
Competition studies
To characterize the pharmacological properties of each ligand, a series of competition studies was conducted. As can be seen from Table 1, 3H-raclopride and 3H-SCH23390 appear to selectively label D, and D, dopamine receptor sites, respectively. (Boyson et al., 1986; Dawson et al., 1986; Bouthenet et al., 1987; Charuchinda et al., 1987; Joyce and Marshall, 1987) . Of the telencephalic regions examined, the caudate-putamen contains the highest density of D, receptor mRNA and D, and D, receptor binding sites. The distribution of D, binding sites appears to be heterogeneous with this structure, with the highest densities in the dorsomedial tips and the dorso-and ventrolatera1 aspects of this nucleus (Fig. 3) . D, receptor binding extends into the ventral striatum and is particularly dense in the rostra1 part of the nucleus accumbens, as well as in the olfactory tubercle. Somewhat reduced levels of 3H-raclopride binding are seen in the caudal two-thirds of the nucleus accumbens, where the binding appears to be less dense than in the caudate-putamen (Fig. 3) . D, receptor sites are also densely distributed in the caudateputamen, with a similar medial-lateral receptor gradient. The dopaminergic receptors differ in the nucleus accumbens, however, where D, sites are dense throughout this nucleus, with particularly high levels observed in the shell of the accumbens (Fig. 3) . D, receptor binding extends ventrally and is dense throughout the olfactory tubercle.
In contrast to the heterogeneous D, ligand distribution, D, receptor mRNA is uniformly distributed in the caudate-putamen (Fig. 3) . D, receptor mRNA levels are also dense in the nucleus accumbens, where the levels appear equivalent to those seen in the caudate-putamen, making the 2 structures appear as a single unit. More ventrally, the olfactory tubercle contains one of the highest concentrations of D, receptor mRNA.
Within the septum, the lateral and medial nuclei demonstrate a light density of D, binding. D, receptor mRNA shows a similar (Fig. 4) . The level of D, ligand binding in this region is found in these nuclei. D, binding sites can also be localized in fairly light, appearing densest in the lateral portion of the nuthe septum, but these sites are predominantly in the lateral cleus. By comparison, cells containing D, receptor mRNA apnucleus.
pear widely distributed throughout the globus pallidus and apThe globus pallidus, a major elSerent target of the caudatepear densely labeled under these hybridization conditions. As putamen, shows D, and D, ligand binding, as well as D, receptor can be appreciated from Figure 4 , given the high amounts of The hippocampal formation with its laminated structure is an excellent tissue for comparing receptor binding and mRNA distributions. Within the hippocampus, D, receptor binding is restricted to the stratum lacunosum moleculare and subiculum, where a light to moderate density of binding is observed (Fig.  5) . D, receptor mRNA, on the other hand, is seen in the pyramidal cell layer (CA 1, CA2, CA3) and in the granular cells of the dentate gyrus. For comparison, moderate densities of D, receptors are observed in the dentate gyrus, with low densities in the stratum moleculare and oriens.
Diencephalon
Compared to the telencephalon, far fewer regions of the diencephalon demonstrate D, receptor binding or mRNA. Within the thalamus, the medial and lateral habenula and the zona incerta have particularly high amounts of D, receptor mRNA (Fig. 6) . By comparison, D, and D, binding can be seen in the lateral habenula, but does not appear to be present in the medial habenula and zona incerta.
In the hypothalamus, D, receptor mRNA is restricted to the anterior and lateral hypothalamic areas, lateral mammillary nucleus, and the paraventricular and ventromedial nuclei, where moderate to low levels are observed. D, receptor binding appears diffuse and light throughout most of the hypothalamus, including the lateral, dorsomedial, ventromedial, and arcuate nuclei. The lateral mammillary nucleus appears to be the exception, with densely localized D, binding sites and mRNA (Fig.  7) . D, binding sites are lightly distributed throughout most of the hypothalamus, including the lateral, ventromedial, and arcuate nuclei, with only the suprachiasmatic nucleus demonstrating a high density of D, sites.
Mesencephalon
Of the mesencephalic structures, the substantia nigra (SN) and ventral tegmental area (VTA) have the highest densities of dopaminergic receptor binding and D, receptor mRNA. D, ligand binding is predominantly in the pars compacta, with light labeling in the pars reticulata (Fig. 7) . Consistent with this localization, D, receptor mRNA is restricted to the cells of the pars compacta, with large cells in the pars reticulata occasionally labeled. D, receptor binding and mRNA appear to show a similar distribution in the VTA, where a moderate density of D, (Fig. 9) . D, receptor mRNA shows a corresponding distribution with high levels of mRNA observed in the intermediate lobe and individually labeled cells in the anterior lobe. In contrast, D, receptors are restricted to the neural lobe, where there is a light density of binding sites.
In situ controls
Comparison of sections hybridized with the 205 bp EcoRI-Xho II probe, which is directed exclusively to the third cytosolic loop, to the longer 495 bp probe, demonstrated that the 2 cRNA probes labeled the same brain structures (Fig. lo) , suggesting the 495 bp probe does not cross-hybridize to other G-protein coupled receptors. As can be seen from Figure 10 , given the higher specific activity of the 495 bp probe, the quality of the in situ signal is improved over the shorter 205 bp cRNA probe.
No specific hybridization was observed in any of the brain areas identified following either RNase pretreatment or "sense"-strand hybridization. Direct comparisons of brain sections with and without RNase pretreatment, or following "sense" and "antisense" hybridization, are illustrated in Figure 11 .
Discussion
In agreement with previous receptor autoradiographic studies (Boysonet al., 1986; Dawsonet al., 1986; Bouthenetet al., 1987; Charuchinda et al., 1987; Richfield et al., 1987; Wamsley et al., 1989) , D, and D, receptor sites are differentially distributed in the CNS and pituitary. D, receptors show a widespread distribution, with binding observed in the basal ganglia, neocortical and paleocortical regions, amygdala, hippocampus, thalamus, and the neural lobe of the pituitary. In contrast, the distribution of D, binding sites appears restricted primarily to the olfactory bulb, basal ganglia, and the intermediate lobe of the pituitary. Given these distinct receptor binding patterns, the distribution of D, receptor mRNA generally corresponds to the D, receptor binding sites labeled by 3H-raclopride. These findings support previous dopamine receptor binding studies in cells transfected with a full length DNA coding for the D, receptor (Bunzow et al., 1988) and extend these findings to the CNS.
Good correspondence between the distributions of D, receptor mRNA and ligand binding can be seen in the caudate-putamen, nucleus accumbens, olfactory tubercle, globus pallidus, lateral mammillary nucleus, substantia nigra, ventral tegmental area, and pituitary gland. Despite such concordance, subtle differences can be seen in the precise localization of the mRNA and binding site even at this level of analysis. For example, within the caudate-putamen D, receptor binding is heterogeneously distributed, being densest in the lateral extent of the nucleus, while the distribution of D, receptor mRNA appears relatively homogeneous and does not demonstrate a mediolateral gradient. This difference may be due to the localization of D, binding sites on cortical projections to the caudate-putamen (e.g., Schwartz et al., 1978) , which would affect the D, ligand binding distribution, but not the mRNA localization within the striatum. Similar subtle differences can be seen in the globus pallidus, where D, receptor binding is lightly and diffusely distributed, while in situ studies demonstrate distinctly labeled pallidal cells. Here too, the difference may be more apparent than real, as the binding sites are likely on pallidal fibers and terminals, while the D, receptor mRNA is localized to the cell bodies of widely distributed pallidal neurons.
While D, receptor binding sites can be observed in many of a number of brain areas that demonstrate a lack of correspondence. These include the neocortex, zona incerta, olfactory bulb, and hippocampus. While it is at present difficult to determine the precise reason for this discrepancy, several possible explanations may be applicable depending on the anatomical region involved.
One possible explanation for a lack of correspondence in some brain regions between receptor binding and mRNA distributions may be inherent technical limitations. The visualization of D, receptor mRNA with S5-labeled riboprobes may be a more sensitive means of detecting dopaminergic receptors than is possible with receptor autoradiography with 3H-labeled ligands. In addition, differential quenching of the 2 isotopes may contribute subtle differences in grain distributions.
Other technical problems may be methodological, such as the . The dark-field images demonstrate that the same brain regions are labeled with each probe, suggesting that the longer 495 bp probe is not crosshybridizing with other 7 transmembrane receptors. Note also that, because of its higher specific activity, the 495 bp probe produces a better quality in situ signal. Abbreviations; CPU, caudate-putamen; SN, substantia nigra; SP, septum.
undesired labeling of other receptor mRNAs or binding sites.
However, the in situ hybridization controls of RNase pretreatment and "sense-strand" labeling would argue that there is specific hybridization. Further, in situ hybridization with the 205 bp cRNA probe that has no sequence identity to any other cloned receptor results in the same mRNA distribution as observed with the longer 495 bp probe. We have used the 495 bp for this mapping study because of the higher specific activity that can be achieved, thereby enhancing the sensitivity and quality of the in situ procedure.
With regards to the receptor binding data, 3H-raclopride and 3H-SCH23390 have been reported to be highly selective ligands for the D, and D, receptor sites, respectively (Iorio et al., 1983; Billard et al., 1984; , and the competition results generated under the autoradiographic conditions used in Figure   II . In situ controls. A and B compare adjacent slides that were either treated with RNase A (30 min, 37°C) (II) or not treated (A) prior to in situ hybridization. C and D compare a second set of adjacent sections hybridized with either "antisense" (c) or "sense" (0) cRNA probes. Note that neither RNase pretreatment nor hybridization with a "sense''-strand cRNA produced a specific signal. Abbreviations: AC& nucleus accumbens; CPU, caudate-putamen; CTX, cortex; HPC, hippocampus; HYP, hypothalamus; THL, thalamus. the present study are in full agreement with these conclusions. 3H-Raclopride is stereoselectively displaced by D, antagonists [e.g., (+)butaclamol, haloperidol, spiperone], while compounds such as (-)butaclamol, clonidine, bremazocine, or propranolol fail to displace this ligand. Similarly, binding sites labeled by 3H-SCH23390 are only displaced by unlabeled SCH23390, and at higher concentrations, (+)butaclamol and chlorpromazine.
While technical limitations may contribute to a lack of correspondence, they cannot explain the marked differences in D, (Halasz and Shepherd, 1983) to the glomerular cells. A similar pattern may be observed in the hippocampus, where D, receptor mRNA is localized in the pyramidal cell layer of the hippocampal formation and the granular cells of the dentate gyrus, while D, receptor binding is restricted to the stratum lacunosum moleculare. The pyramidal cells of the hippocampus and granular cells of the dentate gyrus are oriented with their apical dendrites synapsing in the stratum lacunosum moleculare, so that the D, binding protein may be synthesized in these cells and transported to this dendritic field. This scenario would imply that there is a mechanism involved to direct the transport of the nascent receptor from the site of translation to the point of its subsequent insertion in the membrane.
While such an explanation is appealing, it cannot be determined at present whether the D, receptor binding observed in the stratum lacunosum moleculare is not from an extrahippocampal projection, such as the entorhinal cortex.
be similar to the other G-protein coupled receptors that have been cloned (e.g., muscarinic, cy-and P-adrenergic), one might expect that there may be several receptor subtypes that encode for pharmacologically similar receptor binding sites, making future studies relating D, receptor mRNA (s) and D, binding sites even more challenging. (Dal Toso et al., 1989; Giros et al., 1989; Monsma et al., 1989) have identified a second D, receptor that is identical to the receptor cloned by Bunzow et al. (1988) , but that contains an additional 87 bp sequence encoding 29 amino acids in the putative third cytosolic loop. The function of these 2 receptor isoforms is presently unclear, but preliminary results from this laboratory (unpublished observations) suggest that they have the same distribution in the rat CNS. The cRNA probes used in the present study, however, cannot differentiate between these receptor forms. Given that the insertion is within the third cytosolic loop, some investigators have speculated that it may be involved in coupling to G-proteins (Dal Toso et al., 1989; Giros et al., 1989; Monsma et al., 1989) .
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Many of the anatomical speculations raised in this manuscript are difficult to address at present. The development ofantibodies and immunohistochemical D, receptor studies, in conjunction with tract-tracing, will provide a better understanding of the anatomical distribution of D, receptors and compliment these receptor autoradiography and in situ hybridization results. While such studies are important in understanding the anatomy of the D, receptor, it is clear even from the present results that the point of receptor insertion varies markedly among the neurons expressing D, receptors. In the case of cells in the substantia nigra, for example, the D, receptor is transported to the somatic and dendritic membranes, allowing visualization of a colocalization with the D, receptor mRNA. Neurons in other brain regions, such as the zona incerta, express D, receptors that are transported, most likely, to terminal fields, resulting in a discrepancy in the localization of D, receptor mRNA and binding. While several studies (e.g., Van Der Kooy et al., 1986; Aiso et al., 1987) have demonstrated that receptors are transported via fast axonal flow, the cellular mechanism controlling receptor transport and subsequent membrane insertion is largely unknown (Cullen et al., 1988; Gamou and Shimizu, 1988) . In conclusion, the present study is an initial anatomical examination of the distributions of D, receptor binding sites and mRNA. It combines receptor autoradiographic and in situ hybridization techniques to demonstrate brain regions of good correspondence between the binding site and mRNA and other areas of poor correspondence and possible receptor transport. In addition, it provides a framework for future coregulation studies and a means of asking more intelligent questions concerning the distribution of dopamine receptors and their possible function in the nervous system. If D, receptors prove to
